Stevens, D R <br/><br/>
Response to: lower-dose valganciclovir for prevention of cytomegalovirus after solid organ transplant: an important tradeoff.  [electronic resource] 

 -  Transplant infectious disease : an official journal of the Transplantation Society  Aug 2015 
 - 625-6 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1399-3062 
<br/><br/><label>Standard No.: </label>10.1111/tid.12396  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Allografts--virology<br/>Antiviral Agents--administration & dosage<br/>Cytomegalovirus Infections--prevention & control<br/>Female<br/>Ganciclovir--analogs & derivatives<br/>Graft Rejection--prevention & control<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Kidney Failure, Chronic--surgery<br/>Kidney Transplantation<br/>Male